H Allannic

2.2k total citations · 1 hit paper
55 papers, 1.6k citations indexed

About

H Allannic is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, H Allannic has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Genetics and 16 papers in Surgery. Recurrent topics in H Allannic's work include Thyroid Disorders and Treatments (16 papers), Diabetes and associated disorders (15 papers) and Pancreatic function and diabetes (9 papers). H Allannic is often cited by papers focused on Thyroid Disorders and Treatments (16 papers), Diabetes and associated disorders (15 papers) and Pancreatic function and diabetes (9 papers). H Allannic collaborates with scholars based in France, Switzerland and Poland. H Allannic's co-authors include D Maugendre, B Genetet, M. Delamaire, María de Lourdes Moreno, Y Lorcy, R Fauchet, Isabelle Guilhem, Jacques Orgiazzi, A. Ruelland and L. Campion and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetologia.

In The Last Decade

H Allannic

51 papers receiving 1.6k citations

Hit Papers

Impaired Leucocyte Functions in Diabetic Patients 1997 2026 2006 2016 1997 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impaired Leucocyte Functions in Diabetic Patients
    1997 806 citations M. Delamaire, D Maugendre et al. Diabetic Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Allannic France 15 860 316 299 280 198 55 1.6k
D Maugendre France 18 987 1.1× 392 1.2× 313 1.0× 435 1.6× 201 1.0× 48 1.9k
A C MacCuish United Kingdom 23 856 1.0× 234 0.7× 593 2.0× 521 1.9× 132 0.7× 71 1.9k
Juan Francisco Merino-Torres Spain 19 549 0.6× 231 0.7× 236 0.8× 476 1.7× 60 0.3× 140 1.5k
Glenn W. Geelhoed United States 22 319 0.4× 347 1.1× 151 0.5× 615 2.2× 98 0.5× 87 1.8k
Giuseppe Campagna Italy 23 500 0.6× 170 0.5× 247 0.8× 535 1.9× 160 0.8× 104 1.7k
A.-M. Teppo Finland 21 370 0.4× 271 0.9× 202 0.7× 238 0.8× 28 0.1× 55 1.7k
U Binswanger Switzerland 22 156 0.2× 406 1.3× 172 0.6× 538 1.9× 71 0.4× 158 2.0k
S Lanng Denmark 22 247 0.3× 138 0.4× 132 0.4× 444 1.6× 93 0.5× 32 1.9k
Elio Gulletta Italy 25 277 0.3× 398 1.3× 92 0.3× 304 1.1× 52 0.3× 69 1.9k
Ioannis Ioannidis Greece 22 206 0.2× 548 1.7× 122 0.4× 343 1.2× 180 0.9× 83 1.8k

Countries citing papers authored by H Allannic

Since Specialization
Citations

This map shows the geographic impact of H Allannic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Allannic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Allannic more than expected).

Fields of papers citing papers by H Allannic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Allannic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Allannic. The network helps show where H Allannic may publish in the future.

Co-authorship network of co-authors of H Allannic

This figure shows the co-authorship network connecting the top 25 collaborators of H Allannic. A scholar is included among the top collaborators of H Allannic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Allannic. H Allannic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maugendre, D, et al.. (2008). Iconography : Lymphome primitif des surrénales avec insuffisance surrénalienne latente : à propos d'un nouveau cas et revue de la littérature. 37(402). 1163–5. 2 indexed citations
2.
Grimaldi, André, Valerie Grange, H Allannic, et al.. (2000). Epidemiological analysis of patients with Type 2 diabetes in France. Journal of Diabetes and its Complications. 14(5). 242–249. 15 indexed citations
3.
Maugendre, D, A Gatel, L. Campion, et al.. (1999). Antithyroid drugs and Graves' disease — prospective randomized assessment of long‐term treatment. Clinical Endocrinology. 50(1). 127–132. 88 indexed citations
4.
Sassolas, G., I Bachelot, P. Chanson, et al.. (1999). GH deficiency in adults: an epidemiological approach. European Journal of Endocrinology. 141(6). 595–600. 29 indexed citations
5.
Delamaire, M., et al.. (1997). Impaired Leucocyte Functions in Diabetic Patients. Diabetic Medicine. 14(1). 29–34. 806 indexed citations breakdown →
6.
Maugendre, D, et al.. (1997). Anti-pancreatic autoimmunity and Graves' disease: study of a cohort of 600 Caucasian patients. European Journal of Endocrinology. 137(5). 503–510. 19 indexed citations
7.
Jézéquel, Pascal, Isabelle Guilhem, André Le Treut, et al.. (1996). Identification of a novel mutation (A268G) in exon 8 of the HTRβ gene in a large family with thyroid hormone resistance. Human Mutation. 8(4). 396–396. 7 indexed citations
8.
Maugendre, D, Mehdi Alizadeh, A. Gauthier, et al.. (1996). Genetic heterogeneity between type 1 a and type lb insulin‐dependent diabetes mellitus: HLA Class II and TAP gene analysis. Tissue Antigens. 48(5). 540–548. 11 indexed citations
9.
10.
Allannic, H, et al.. (1991). [Synthetic antithyroid drugs and Basedow's disease or the choice of a therapeutic strategy].. PubMed. 20(14). 645–6, 649. 7 indexed citations
11.
Bardet, Stéphane, V. Rohmer, D Maugendre, et al.. (1991). Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34(9). 648–654. 17 indexed citations
12.
Bardet, Stéphane, V. Rohmer, D Maugendre, et al.. (1990). β-Cell Cytoadherent Lymphocytes in Some Subjects at Risk for Type 1 (Insulin-Dependent) Diabetes: Progression to Diabetes within 2 Years*. The Journal of Clinical Endocrinology & Metabolism. 71(5). 1310–1317. 2 indexed citations
13.
Allannic, H, et al.. (1990). Antithyroid Drugs and Graves' Disease: A Prospective Randomized Evaluation of the Efficacy of Treatment Duration. The Journal of Clinical Endocrinology & Metabolism. 70(3). 675–679. 136 indexed citations
14.
Allannic, H. (1987). Strategy for Antithyroid Drug Therapy in Graves’ Disease. Hormone Research. 26(1-4). 146–153. 2 indexed citations
15.
Lorcy, Y, et al.. (1984). [Gastric bypass in the treatment of major obesity. 15 cases].. PubMed. 13(41). 2489–92. 1 indexed citations
16.
Allannic, H, R Fauchet, Y Lorcy, et al.. (1983). Properdin factor B (Bf) and glyoxalase in Graves' disease. European Journal of Endocrinology. 102(1). 57–61. 2 indexed citations
17.
Massart, C., et al.. (1980). [Gynecomastia and iodine induced thyrotoxicosis during a benziodarone treatment (author's transl)].. PubMed. 56(11-12). 572–4.
18.
Allannic, H, R Fauchet, Y Lorcy, et al.. (1980). HLA and Graves' Disease: An Association with HLADRw3. The Journal of Clinical Endocrinology & Metabolism. 51(4). 863–867. 59 indexed citations
19.
Allannic, H, et al.. (1976). [Proceedings: Hyperthyroidism with pyramidal signs: report of a case (author's transl)].. PubMed. 36(6). 365–6. 1 indexed citations
20.
Allannic, H, et al.. (1975). [Kala-azar in adults in western France during the last 15 years].. PubMed. 67(5). 503–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Maugendre Breakdown of academic impact, for papers by A C MacCuish Breakdown of academic impact, for papers by Juan Francisco Merino-Torres Breakdown of academic impact, for papers by Glenn W. Geelhoed Breakdown of academic impact, for papers by Giuseppe Campagna Breakdown of academic impact, for papers by A.-M. Teppo Breakdown of academic impact, for papers by U Binswanger Breakdown of academic impact, for papers by S Lanng Breakdown of academic impact, for papers by Elio Gulletta Breakdown of academic impact, for papers by Ioannis Ioannidis
Rankless by CCL
2026